The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-11
DOI
10.1002/med.21661
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A
- (2019) Thomas G. Moens et al. ACTA NEUROPATHOLOGICA
- Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study
- (2019) Ryuji Kaji et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
- (2019) Joseph R. Klim et al. NATURE NEUROSCIENCE
- Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration
- (2019) Ze’ev Melamed et al. NATURE NEUROSCIENCE
- Therapeutic Dissolution of Aberrant Phases by Nuclear-Import Receptors
- (2019) Lin Guo et al. TRENDS IN CELL BIOLOGY
- ALSUntangled 48: Perampanel (Fycompa)
- (2019) Rick Bedlack Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase
- (2019) James Shorter et al. Cold Spring Harbor Perspectives in Biology
- Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity
- (2019) Yong-Jie Zhang et al. SCIENCE
- Cytotoxic CD8+T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons
- (2019) Emmanuelle Coque et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43
- (2019) Jacob R. Mann et al. NEURON
- Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death
- (2019) Fatima Gasset-Rosa et al. NEURON
- The role of liquid-liquid phase separation in aggregation of the TDP-43 low complexity domain
- (2019) W. Michael Babinchak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins
- (2019) Yongjia Duan et al. CELL RESEARCH
- AAA+ protein-based technologies to counter neurodegenerative disease
- (2019) Zachary M. March et al. BIOPHYSICAL JOURNAL
- Genetics of amyotrophic lateral sclerosis: A review
- (2019) Stéphane Mathis et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function
- (2019) Michael R. White et al. MOLECULAR CELL
- Tailored treatment for ALS poised to move ahead
- (2019) Carrie Arnold NATURE MEDICINE
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting RIPK1 for the treatment of human diseases
- (2019) Alexei Degterev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology
- (2019) Peipei Zhang et al. eLife
- Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials
- (2019) Stephen A. Goutman et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antisense therapies pose a regulatory conundrum
- (2019) Carrie Arnold NATURE MEDICINE
- RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats
- (2019) Shizuka B. Yamada et al. NATURE NEUROSCIENCE
- Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD
- (2019) Mark Y. Fang et al. NEURON
- The nucleolus functions as a phase-separated protein quality control compartment
- (2019) F. Frottin et al. SCIENCE
- Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
- (2019) Jesus S. Mora et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Inhibition of Axon Regeneration by Liquid-like TIAR-2 Granules
- (2019) Matthew G. Andrusiak et al. NEURON
- Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
- (2019) Amber Tariq et al. Cell Reports
- High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation
- (2019) Katelyn M. Green et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound
- (2019) Agessandro Abrahao et al. Nature Communications
- CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation
- (2019) Weiwei Cheng et al. NEURON
- Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
- (2018) Caroline Moreau et al. ANTIOXIDANTS & REDOX SIGNALING
- Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites
- (2018) Takuya Yoshizawa et al. CELL
- Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation
- (2018) Mario Hofweber et al. CELL
- Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains
- (2018) Lin Guo et al. CELL
- FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions
- (2018) Seema Qamar et al. CELL
- Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
- (2018) Maria O. Kovalchuk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Neuronal autophagy and intercellular regulation of homeostasis in the brain
- (2018) Aditi Kulkarni et al. CURRENT OPINION IN NEUROBIOLOGY
- Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model
- (2018) Amrutha Swaminathan et al. HUMAN MOLECULAR GENETICS
- Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
- (2018) Albert C Ludolph et al. LANCET NEUROLOGY
- Rapamycin treatment for amyotrophic lateral sclerosis
- (2018) Jessica Mandrioli et al. MEDICINE
- TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
- (2018) Ching-Chieh Chou et al. NATURE NEUROSCIENCE
- Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressiveSOD1ALS
- (2018) Michael Benatar et al. NEUROLOGY
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of Tirasemtiv, the First Direct Fast Skeletal Muscle Troponin Activator
- (2018) Scott E. Collibee et al. ACS Medicinal Chemistry Letters
- Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization
- (2018) Emile S. Pinarbasi et al. Scientific Reports
- Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1
- (2018) Helena Ederle et al. Scientific Reports
- TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia
- (2018) Hilary C. Archbold et al. Scientific Reports
- Nuclear Export Inhibition Enhances HLH-30/TFEB Activity, Autophagy, and Lifespan
- (2018) Melissa J. Silvestrini et al. Cell Reports
- Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS
- (2018) Stephen A. Goutman et al. Annals of Clinical and Translational Neurology
- Stem cell transplantation for amyotrophic lateral sclerosis
- (2018) Robert H. Baloh et al. CURRENT OPINION IN NEUROLOGY
- The molecular language of membraneless organelles
- (2018) Edward Gomes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization
- (2018) Leeanne McGurk et al. MOLECULAR CELL
- Rasagiline for Amyotrophic Lateral Sclerosis: a Randomized Controlled Trial
- (2018) Jeffrey M Statland et al. MUSCLE & NERVE
- C9orf72-mediated ALS and FTD: multiple pathways to disease
- (2018) Rubika Balendra et al. Nature Reviews Neurology
- Axonal G3BP1 stress granule protein limits axonal mRNA translation and nerve regeneration
- (2018) Pabitra K. Sahoo et al. Nature Communications
- Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
- (2018) L. McGurk et al. Acta Neuropathologica Communications
- Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP‐100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial
- (2018) Hitoshi Warita et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A pilot trial of RNS60 in amyotrophic lateral sclerosis
- (2018) Sabrina Paganoni et al. MUSCLE & NERVE
- Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
- (2018) Tae-In Kam et al. SCIENCE
- Theme 9 Clinical trials and trial design
- (2018) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II
- (2018) Liang-min Liu et al. Brain and Behavior
- Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015
- (2018) Paul Mehta et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination
- (2017) Kyota Yasuda et al. JOURNAL OF CELL BIOLOGY
- Surveillance of using novel free radical scavenger, edaravone to investigate survival effect for ALS patients in Japan (SUNRISE Japan): A study design
- (2017) M. Hirai et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Vincent Meininger et al. LANCET NEUROLOGY
- Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability
- (2017) James D. Berry et al. MUSCLE & NERVE
- CK-2127107 amplifies skeletal muscle response to nerve activation in humans
- (2017) Jinsy A. Andrews et al. MUSCLE & NERVE
- Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
- (2017) Lindsay A. Becker et al. NATURE
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
- (2017) David R Corey NATURE NEUROSCIENCE
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- The role of mitochondria in amyotrophic lateral sclerosis
- (2017) Emma F. Smith et al. NEUROSCIENCE LETTERS
- Amyotrophic Lateral Sclerosis
- (2017) Robert H. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liquid phase condensation in cell physiology and disease
- (2017) Yongdae Shin et al. SCIENCE
- Edaravone suppresses retinal ganglion cell death in a mouse model of normal tension glaucoma
- (2017) Kei Akaiwa et al. Cell Death & Disease
- Theme 9 Clinical trials
- (2017) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis
- (2017) Robert L. Sufit et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord
- (2017) James B. Hilton et al. Scientific Reports
- An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
- (2016) Ying-Qing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanistic and Structural Insights into the Prion-Disaggregase Activity of Hsp104
- (2016) Elizabeth A. Sweeny et al. JOURNAL OF MOLECULAR BIOLOGY
- Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
- (2016) Emiliano Trias et al. Journal of Neuroinflammation
- Compartment-Specific Regulation of Autophagy in Primary Neurons
- (2016) Sandra Maday et al. JOURNAL OF NEUROSCIENCE
- Transplantation of spinal cord–derived neural stem cells for ALS
- (2016) Jonathan D. Glass et al. NEUROLOGY
- A randomized trial of mexiletine in ALS
- (2016) Michael D. Weiss et al. NEUROLOGY
- RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
- (2016) Yasushi Ito et al. SCIENCE
- ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain
- (2016) Alexander E. Conicella et al. STRUCTURE
- The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice
- (2016) Megumi Akamatsu et al. Scientific Reports
- Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies
- (2016) Lin Guo et al. Cold Spring Harbor Perspectives in Medicine
- A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis
- (2016) Jeremy M. Shefner et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis
- (2016) Panayiota Petrou et al. JAMA Neurology
- Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutase
- (2016) Eiichi Tokuda et al. Acta Neuropathologica Communications
- Disparate Mutations Confer Therapeutic Gain of Hsp104 Function
- (2015) Meredith E. Jackrel et al. ACS Chemical Biology
- Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
- (2015) Adam K. Walker et al. ACTA NEUROPATHOLOGICA
- Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization
- (2015) Amandine Molliex et al. CELL
- A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation
- (2015) Avinash Patel et al. CELL
- Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
- (2015) A. E. Elia et al. EUROPEAN JOURNAL OF NEUROLOGY
- Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity
- (2015) Zhouteng Tao et al. HUMAN MOLECULAR GENETICS
- Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
- (2015) Giuseppe Lauria et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins
- (2015) Yuan Lin et al. MOLECULAR CELL
- The C9orf72 repeat expansion disrupts nucleocytoplasmic transport
- (2015) Ke Zhang et al. NATURE
- GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
- (2015) Brian D. Freibaum et al. NATURE
- Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress
- (2015) Mohammad-Saeid Jami et al. NEUROCHEMISTRY INTERNATIONAL
- ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function
- (2015) Tetsuro Murakami et al. NEURON
- Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS
- (2015) Helene Tran et al. NEURON
- PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
- (2015) Antonella Cardinale et al. PLoS One
- Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA
- (2015) A. C. Woerner et al. SCIENCE
- Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD)
- (2015) Serena Lattante et al. TRENDS IN GENETICS
- A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial
- (2015) Kazumoto Shibuya et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Metabolic and Chaperone Gene Loss Marks the Origin of Animals: Evidence for Hsp104 and Hsp78 Chaperones Sharing Mitochondrial Enzymes as Clients
- (2015) Albert J. Erives et al. PLoS One
- Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
- (2015) André Maier et al. PLoS One
- C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration
- (2014) Stephanie May et al. ACTA NEUROPATHOLOGICA
- Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: Phase 1 trial outcomes
- (2014) Eva L. Feldman et al. ANNALS OF NEUROLOGY
- Autophagy and Its Normal and Pathogenic States in the Brain
- (2014) Ai Yamamoto et al. Annual Review of Neuroscience
- Altered macroautophagy in the spinal cord of SOD1 mutant mice
- (2014) Liang Li et al. Autophagy
- Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events
- (2014) Meredith E. Jackrel et al. CELL
- Reversing deleterious protein aggregation with re-engineered protein disaggregases
- (2014) Meredith E Jackrel et al. CELL CYCLE
- Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins
- (2014) M. E. Jackrel et al. Disease Models & Mechanisms
- A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis
- (2014) T. Lenglet et al. EUROPEAN JOURNAL OF NEUROLOGY
- Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
- (2014) B. R. Roberts et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
- (2014) Merit E Cudkowicz et al. LANCET NEUROLOGY
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
- (2014) Sami J Barmada et al. Nature Chemical Biology
- Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death
- (2014) Xinmei Wen et al. NEURON
- Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
- (2014) Ashley E. Frakes et al. NEURON
- Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
- (2014) Brian J. Wainger et al. Cell Reports
- Spatial quality control bypasses cell-based limitations on proteostasis to promote prion curing
- (2014) Courtney L Klaips et al. eLife
- Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
- (2014) Michael R. Jablonski et al. Annals of Clinical and Translational Neurology
- Analysis of graft survival in a trial of stem cell transplant in ALS
- (2014) Tezeta Tadesse et al. Annals of Clinical and Translational Neurology
- Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins
- (2013) Kohji Mori et al. ACTA NEUROPATHOLOGICA
- Stress granules as crucibles of ALS pathogenesis
- (2013) Yun R. Li et al. JOURNAL OF CELL BIOLOGY
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
- (2013) Merit E Cudkowicz et al. LANCET NEUROLOGY
- Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
- (2013) LANCET NEUROLOGY
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
- (2013) A. Chiò et al. NEUROEPIDEMIOLOGY
- Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
- (2013) Shuo-Chien Ling et al. NEURON
- RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
- (2013) T. Zu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS
- (2013) Ettore Beghi et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- The 70th Anniversary of the Death of Lou Gehrig
- (2012) Frank Brennan American Journal of Hospice & Palliative Medicine
- Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients
- (2012) Morgan E. DeSantis et al. CELL
- Suppression of Nuclear Factor-κB Activation and Inflammation in Microglia by Physically Modified Saline
- (2012) Saurabh Khasnavis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial
- (2012) Esther Verstraete et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
- (2012) Elisa Majounie et al. LANCET NEUROLOGY
- Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases
- (2012) Alan J Russell et al. NATURE MEDICINE
- Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates
- (2012) Sarah J. Parker et al. NEUROCHEMISTRY INTERNATIONAL
- A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
- (2012) Luc Dupuis et al. PLoS One
- Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis
- (2012) Johannes Brettschneider et al. PLoS One
- Lumbar Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis: Results of a Phase I Trial in 12 Patients
- (2012) Jonathan D. Glass et al. STEM CELLS
- Differential Involvement of Optineurin in Amyotrophic Lateral Sclerosis With or Without SOD1 Mutations
- (2011) Han-Xiang Deng ARCHIVES OF NEUROLOGY
- Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients
- (2011) T. Lee et al. HUMAN MOLECULAR GENETICS
- Autophagy in Spinal Cord Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis
- (2011) Shoichi Sasaki JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Astrocytes from familial and sporadic ALS patients are toxic to motor neurons
- (2011) Amanda M Haidet-Phillips et al. NATURE BIOTECHNOLOGY
- Translational stem cell therapy for amyotrophic lateral sclerosis
- (2011) Nicholas M. Boulis et al. Nature Reviews Neurology
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- (2011) Mariely DeJesus-Hernandez et al. NEURON
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
- (2011) Alan E. Renton et al. NEURON
- A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis
- (2010) Mamede de Carvalho et al. Amyotrophic Lateral Sclerosis
- A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?
- (2010) Mark C. Bellingham CNS Neuroscience & Therapeutics
- Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules
- (2010) Daryl A. Bosco et al. HUMAN MOLECULAR GENETICS
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
- (2010) Andrew C. Elden et al. NATURE
- Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue
- (2010) Liqun Liu-Yesucevitz et al. PLoS One
- A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model
- (2010) A. S. Tsvetkov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
- (2009) Elijah W. Stommel et al. Amyotrophic Lateral Sclerosis
- A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
- (2009) Robert M. Pascuzzi et al. Amyotrophic Lateral Sclerosis
- Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
- (2009) Vincent Meininger et al. Amyotrophic Lateral Sclerosis
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
- (2009) Petra Kaufmann et al. ANNALS OF NEUROLOGY
- Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
- (2009) Siân C. Barber et al. FREE RADICAL BIOLOGY AND MEDICINE
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS
- (2008) Jeffrey Rosenfeld et al. Amyotrophic Lateral Sclerosis
- Design, power, and interpretation of studies in the standard murine model of ALS
- (2008) Sean Scott et al. Amyotrophic Lateral Sclerosis
- Phase 2 study of sodium phenylbutyrate in ALS
- (2008) Merit E. Cudkowicz et al. Amyotrophic Lateral Sclerosis
- Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
- (2008) Hidefumi Ito et al. EXPERIMENTAL NEUROLOGY
- Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells
- (2008) Takashi Nonaka et al. FEBS LETTERS
- Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis
- (2008) M. R. Vargas et al. JOURNAL OF NEUROSCIENCE
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
- (2008) E. J. Sorenson et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More